Next-Generation Sequencing Assay for biomarker analysis
The assay is a multi-biomarker next-generation sequencing (NGS) assay that enables detection of thousands of variants relevant to solid tumors. This assay allows concurrent analysis of DNA & RNA to simultaneously detect multiple types of variants.
Intelligent NGS Assay
The biomarkers included in our assay were selected by the oncology informatics team based on proprietary databases, peer-reviewed literature, and competitive industry data, and confirmed with industry-leading pharmaceutical partners.
Prognosis of disease
Prediction of Potential Metastasis
Relevant, on-going clinical trial information